DUBLIN, July 3, 2013 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/4bm2ld/pediatric) has announced the addition of the "Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
Worldwide pediatric vaccine market has been growing rapidly over the last five years as it has doubled its market share in 2011 compared to 2005. The worldwide pediatrics vaccine market is expected to be more than US$ 23 Billion by 2015 growing with a single digit CAGR during 2012 - 2015. This incremental growth has been due to blockbuster vaccines (Prevnar7, Prevnar 13, Rotarix and Rotateq) sales in Billion of US$ which made a significant contribution.
It is predicted that Pediatric proprietary vaccines will lead the segment with little less than 60% market share by 2015.The combinations & boosters and enhanced pediatric vaccines market are expected to show stagnant growth in future due to lower margins and the mature nature of these markets. Pneumococcal, DTP and Varicella together all these three vaccines control 55% of the market share in 2011.
In number of cases Polio, Haemophiilus Influenzae Type B (HIB) and MMR cases have shown decline continuously from the year 2001 till 2011. Polio remains endemic merely in three countries and the good news is that India has not reported a single case from the past two years and on the verge of being called a polio free country.
DTP are the most utilized vaccines in the pediatric vaccines market which contributed less than 10,000 Million doses in 2011. Pediatric Hepatitis and Polio vaccines are also mostly used vaccines which consumed more than 6,000 Million doses in 2011. In case of Rotavirus vaccine although the price of Rotavirus vaccine has declined but still its present prices are expensive than other pediatric vaccines. However despite all the impediments pediatric vaccines industry is expected to remain highly active in the future, fueled by the encouragement and financing from governments and other health organizations.
All the Pediatric Vaccines in this Report have been Studied from Four View Points:
- Number of Cases Reported for all 9 Pediatric Diseases by Region from 2001 to 2011
- Number of Doses Reported and Forecast for all 9 Pediatric Vaccine from 2005 to 2015
- Immunization Coverage for all 9 Pediatric Vaccines and Forecast from 2005 to 2015
- Market Size for all 9 Pediatric Vaccines and Forecast from 2005 to 2015
Key Topics Covered:
1. Executive Summary
2. Worldwide Pediatric Vaccines Market and Forecast (2006 - 2015)
3. Worldwide - Pediatric Vaccines Market Share & Forecast (Sector wise) (2005 - 2015)
4. Worldwide - Pediatric Vaccines Market Share & Forecast (Disease wise) (2006 - 2015)
5. By Sector - Pediatric Vaccines Market and Forecast (2005 - 2015)
5.1 Worldwide - Pediatric Combinations & Boosters Vaccines Market
5.2 Worldwide - Pediatric Enhanced Combinations Vaccines Market
5.3 Worldwide - Pediatric Proprietary Vaccines Market
6. Major Pediatric Vaccines Cases, Doses, Immunization Coverage, Market and Forecast
6.1 Measles, Mumps & Rubella (MMR) Vaccines and Forecast (2005 - 2015)
6.2 Haemophilus Influenzae Type B (HIB) Vaccines and Forecast (2005 - 2015)
6.3 Polio Vaccines and Forecast (2005 - 2015)
6.4 Diphtheria, Tetanus & Pertussis (Combos) Vaccines and Forecast (2005 - 2015)
6.5 Pneumococcal Vaccines and Forecast (2005 - 2015)
6.6 Rotavirus Vaccine and Forecast (2006 - 2015)
6.7 Hepatitis Pediatric Vaccines and Forecast (2005 - 2015)
6.8 Varicella/Chicken Pox Vaccines and Forecast (2005 - 2015)
6.9 Other Pediatric Vaccines and Forecast (2005 - 2015)
7. Growth Drivers of Pediatric Vaccines Market
7.1 Reduced Price on Rotavirus Vaccines: Enough to Facilitate Growth but More Still Needs To Be Done
7.2 GAVI Model Increases Vaccine Manufacturers
7.3 WHO Global Vaccine Action Plan (2011 - 2020)
8. Challenges of Pediatric Vaccine Market
For more information visit http://www.researchandmarkets.com/research/4bm2ld/pediatric
SOURCE Research and Markets